Zotefoams (ZTF) Price Target Raised to GBX 570

Zotefoams (LON:ZTF) had its price objective upped by Canaccord Genuity from GBX 550 ($7.60) to GBX 570 ($7.88) in a research report issued to clients and investors on Wednesday. The firm presently has a “buy” rating on the stock. Canaccord Genuity’s target price indicates a potential upside of 11.76% from the company’s previous close.

Shares of Zotefoams (LON ZTF) opened at GBX 510 ($7.05) on Wednesday. Zotefoams has a fifty-two week low of GBX 280 ($3.87) and a fifty-two week high of GBX 532 ($7.35). The stock has a market cap of $225.14 and a P/E ratio of 3,642.86.

In other Zotefoams news, insider Doug Robertson purchased 5,416 shares of the firm’s stock in a transaction on Wednesday, December 20th. The shares were acquired at an average cost of GBX 459 ($6.34) per share, for a total transaction of £24,859.44 ($34,345.73). Insiders acquired 5,483 shares of company stock worth $2,515,772 over the last quarter.

ILLEGAL ACTIVITY NOTICE: “Zotefoams (ZTF) Price Target Raised to GBX 570” was reported by Markets Daily and is owned by of Markets Daily. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.themarketsdaily.com/2018/03/14/zotefoams-ztf-price-target-raised-to-gbx-570.html.

About Zotefoams

Zotefoams plc is a United Kingdom-based cellular material technology company. The Company is engaged in the manufacture and sale of cross-linked block foams. The Company’s segments include Polyolefins, High-Performance Products (HPP) and MuCell Extrusion LLC (MEL). Polyolefins foams are made from olefinic homopolymer and copolymer resin.

Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply